{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:59Z","timestamp":1761513719940,"version":"3.41.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejim.2015.10.017","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T07:30:23Z","timestamp":1446795023000},"page":"813-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular outcomes and conventional risk factors in non-diabetic adult patients with GH deficiency: A long-term retrospective cohort study"],"prefix":"10.1016","volume":"26","author":[{"given":"Cesare","family":"de Gregorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana Ruxandra","family":"Cotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olimpia","family":"Trio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cusm\u00e0 Piccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Curt\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2015.10.017_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1999.00682.x","article-title":"Cardiovascular disease and risk factors in adults with hypopituitarism","volume":"50","author":"Beshah","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midland Prospective Hypopituitarism Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.10.017_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","article-title":"Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities","volume":"55","author":"Abdu","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.1.02179","article-title":"Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults. A KIMS database analysis","volume":"155","author":"Abs","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/eje.0.1410481","article-title":"Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socioeconomic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group","volume":"141","author":"Sanmarti","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/acta.0.1290195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.2008.03292.x","article-title":"The GH\u2013IGF-I axis and the cardiovascular system: clinical implications","volume":"69","author":"Colao","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF03346692","article-title":"High prevalence of coronary calcifications and increased risk for coronary heart disease in adults with growth hormone deficiency","volume":"34","author":"Cannav\u00f2","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2015.10.017_bb0045","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of growth hormone treatment in adults","volume":"96","author":"Van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2015.10.017_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11102-013-0469-1","article-title":"Pituitary disease mortality: is it fiction?","volume":"16","author":"Erfurth","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ejim.2015.10.017_bb0055","first-page":"243","article-title":"Hypertension counteracts potential benefits of GH replacement therapy on left ventricular remodeling in adults with growth hormone deficiency","volume":"36","author":"de Gregorio","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejim.2015.10.017_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000318503","article-title":"Testing growth hormone deficiency in adults","volume":"38","author":"Gabellieri","year":"2010","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ejim.2015.10.017_bb0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00004872-200305000-00001","article-title":"European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement","volume":"21","author":"O' Brien","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2015.10.017_bb0070","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2015.10.017_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.ejim.2015.10.017_bb0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/0735-1097(94)90390-5","article-title":"Assessment of left ventricular function by the midwall fractional shortening\/end-systolic stress relation in human hypertension","volume":"23","author":"de Simone","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0085","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1530\/EJE-09-0291","article-title":"Cardiovascular risk factors in hypopituitary GH-deficient adults","volume":"161","author":"Verhelst","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jc.2013-2394","article-title":"Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH\u2014an update","volume":"99","author":"Gazzaruso","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2015.10.017_bb0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.2007.02947.x","article-title":"Excess mortality in women with pituitary disease: a meta-analysis","volume":"67","author":"Nielsen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejim.2015.10.017_bb0100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood Short stature: preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2015.10.017_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12020-012-9769-x","article-title":"Growth hormone deficiency and cardiovascular risk: do we need additional markers?","volume":"42","author":"Gola","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.ejim.2015.10.017_bb0110","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1530\/EJE-09-0287","article-title":"Safety aspects of GH replacement","volume":"161","author":"Svensson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","article-title":"GH and the cardiovascular system: an update on a topic at heart","volume":"48","author":"Isgaard","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ejim.2015.10.017_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gheart.2012.12.004","article-title":"Hypertension and cardiovascular disease: contributions of the Framingham Heart Study","volume":"8","author":"Franklin","year":"2013","journal-title":"Glob Heart"},{"key":"10.1016\/j.ejim.2015.10.017_bb0125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.14310\/horm.2002.1510","article-title":"Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency","volume":"14","author":"Boschetti","year":"2015","journal-title":"Hormones"},{"key":"10.1016\/j.ejim.2015.10.017_bb0130","first-page":"E219","article-title":"Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement","volume":"267","author":"Cittadini","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-6-1","article-title":"Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case\u2013control study","volume":"6","author":"de Gregorio","year":"2006","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ejim.2015.10.017_bb0140","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/01.CIR.83.5.1676","article-title":"Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy","volume":"83","author":"Shimuzu","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2015.10.017_bb0145","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2007.04.051","article-title":"Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency","volume":"100","author":"Cho","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2015.10.017_bb0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11102-011-0356-6","article-title":"The metabolic consequences of thyroxine replacement in adult hypopituitary patients","volume":"15","author":"Filipsson Nystr\u00f6m","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ejim.2015.10.017_bb0155","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1210\/jc.2013-1610","article-title":"Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients","volume":"98","author":"Klose","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2015.10.017_bb0160","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and co-morbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2015.10.017_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.10.017_bb0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ghir.2013.09.001","article-title":"Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation","volume":"23","author":"Elbornsson","year":"2013","journal-title":"Growth Horm IGF Res"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515003465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515003465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:44:58Z","timestamp":1748684698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0953620515003465"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.10.017","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular outcomes and conventional risk factors in non-diabetic adult patients with GH deficiency: A long-term retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}